Osmind is a healthcare technology startup providing software and clinical insights for mental health.
Osmind is on a mission to maximize access to innovative mental health treatments.
Osmind was founded in 2020 by Lucia Huang and Jimmy Qian. The company is headquartered in Mountain View, California.
Osmind helps the medical community administer, track, and study the efficacy of interventions such as ketamine, SPRAVATO®, and transcranial magnetic stimulation for the 14 million U.S. patients living with moderate and serious mental illness.
The Osmind EHR platform is designed for the needs of mental health clinicians, including psychiatrists and other specialties, with tools such as streamlined charting workflows, secure patient engagement, and automated outcomes tracking.
OsMind also developed software that helps track patient progress both to suggest treatment options for their psychiatrists, as well as providing de-identified data that can be used by researchers looking to develop better treatments for certain conditions.
Osmind is backed by General Catalyst, Tiger Global, DFJ Growth, Y Combinator, AME Cloud Ventures, Susa Ventures, Offline Ventures, Future Ventures, Lachy Groom, and others. The company raised $40M in Series B round on May 10, 2022. This brings Osmind's total funding to $57.2M to date.